The Latest

Spotlight on Innovation

Medication-assisted treatment (MAT) is critical for successful long-term management of opioid use disorder, allowing patients to focus on reintegrating into their lives and communities. Braeburn is working to deliver flexible-dose, next-generation therapies to manage this chronic brain disease – therapies that are administered directly by health care professionals, which may potentially minimize the risks of misuse and improve treatment adherence. Read more about MAT and Braeburn here.


Previous Events